Portfolio company
Apreo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage medical device company develops an implantable airway scaffold to treat patients suffering from severe emphysema.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Apieron
This company develops biosensor devices to monitor exhaled nitric oxide for asthma management in patients and clinical settings.
AirNexis
This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Avelo
This company develops non-invasive breath sampling kits for the molecular diagnosis of respiratory infections like tuberculosis and pneumonia for clinicians and patients.
Activaero
The company develops controlled breathing systems and smart nebulisers to deliver inhaled drugs for patients with severe respiratory diseases.
Ryme Medical
The company develops catheter-based therapies for patients with chronic obstructive pulmonary disease to improve airflow and reduce symptoms through targeted lung denervation.
APrevent Medical
This company develops adjustable laryngeal implants and speech conversion software for patients suffering from vocal fold paralysis and speech disorders.
Avivomed
This medical device company develops neuromodulation systems to treat patients suffering from obstructive sleep apnea and other chronic conditions.
